AT399885B - Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren - Google Patents

Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren

Info

Publication number
AT399885B
AT399885B AT0168387A AT168387A AT399885B AT 399885 B AT399885 B AT 399885B AT 0168387 A AT0168387 A AT 0168387A AT 168387 A AT168387 A AT 168387A AT 399885 B AT399885 B AT 399885B
Authority
AT
Austria
Prior art keywords
cell lines
monoclonal antibodies
producing cell
produce monoclonal
produce
Prior art date
Application number
AT0168387A
Other languages
German (de)
English (en)
Other versions
ATA168387A (de
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of ATA168387A publication Critical patent/ATA168387A/de
Application granted granted Critical
Publication of AT399885B publication Critical patent/AT399885B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT0168387A 1986-07-03 1987-07-03 Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren AT399885B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15

Publications (2)

Publication Number Publication Date
ATA168387A ATA168387A (de) 1994-12-15
AT399885B true AT399885B (de) 1995-08-25

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0168387A AT399885B (de) 1986-07-03 1987-07-03 Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren

Country Status (19)

Country Link
JP (1) JP2639422B2 (xx)
KR (1) KR910002373B1 (xx)
AT (1) AT399885B (xx)
AU (1) AU615162B2 (xx)
BE (1) BE1000743A3 (xx)
CH (1) CH677796A5 (xx)
DE (1) DE3722098C2 (xx)
DK (1) DK172840B1 (xx)
ES (1) ES2013321A6 (xx)
FR (1) FR2601458B1 (xx)
GB (1) GB2192185B (xx)
IE (1) IE60888B1 (xx)
IL (1) IL83047A (xx)
IT (1) IT1221940B (xx)
LU (1) LU86938A1 (xx)
NL (1) NL194961C (xx)
OA (1) OA08629A (xx)
PT (1) PT85247B (xx)
SE (1) SE506421C2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
JPH02299594A (ja) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd ヒトモノクローナル抗体およびその製法
AU5525490A (en) * 1989-04-14 1990-11-16 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
DE69131861T2 (de) * 1990-01-18 2000-05-18 Cura Nominees Pty Ltd Glykoalkaloide
CA2751433A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
EP2542577A1 (en) * 2010-03-01 2013-01-09 Lostam Biopharmaceuticals Ltd Improved therapeutic antibodies against flagellated pseudomonas aeruginosa

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001807A1 (en) * 1984-09-07 1986-03-27 Technology Licence Company Limited Monoclonal antibodies and their use
EP0176365A2 (en) * 1984-09-26 1986-04-02 Sumitomo Chemical Company, Limited Human monoclonal antibody and its preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5991786A (en) * 1985-06-06 1987-01-07 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001807A1 (en) * 1984-09-07 1986-03-27 Technology Licence Company Limited Monoclonal antibodies and their use
EP0176365A2 (en) * 1984-09-26 1986-04-02 Sumitomo Chemical Company, Limited Human monoclonal antibody and its preparation

Also Published As

Publication number Publication date
GB8715347D0 (en) 1987-08-05
IL83047A (en) 1992-12-01
NL194961C (nl) 2003-09-02
AU615162B2 (en) 1991-09-26
ES2013321A6 (es) 1990-05-01
OA08629A (en) 1988-11-30
FR2601458A1 (fr) 1988-01-15
SE8702734L (sv) 1988-01-04
IL83047A0 (en) 1987-12-31
DK172840B1 (da) 1999-08-09
JPS63102697A (ja) 1988-05-07
CH677796A5 (xx) 1991-06-28
BE1000743A3 (fr) 1989-03-28
AU7495887A (en) 1988-01-07
SE506421C2 (sv) 1997-12-15
SE8702734D0 (sv) 1987-07-02
NL194961B (nl) 2003-05-01
KR880001815A (ko) 1988-04-27
JP2639422B2 (ja) 1997-08-13
DE3722098C2 (de) 1998-06-04
IE871769L (en) 1988-01-03
GB2192185A (en) 1988-01-06
PT85247B (pt) 1990-06-29
KR910002373B1 (ko) 1991-04-20
DE3722098A1 (de) 1988-03-03
NL8701554A (nl) 1988-02-01
IT1221940B (it) 1990-08-31
DK336687A (da) 1988-01-04
LU86938A1 (fr) 1988-02-02
PT85247A (en) 1987-08-01
DK336687D0 (da) 1987-06-30
IE60888B1 (en) 1994-08-24
ATA168387A (de) 1994-12-15
IT8721163A0 (it) 1987-07-02
GB2192185B (en) 1991-01-16
FR2601458B1 (fr) 1992-08-21

Similar Documents

Publication Publication Date Title
DE3587360D1 (de) Verfahren zur herstellung von chimaerischen monoklonalen antikoerpern.
DE3587442D1 (de) Verfahren zur herstellung von polysilsesquioxanen.
DE3485880D1 (de) Verfahren zur herstellung von halbleiteranordnungen.
DE3486147D1 (de) Verfahren zur herstellung von l-isoleucin.
DE3575423D1 (de) Verfahren zur herstellung von heteroaryloxyacetamiden.
DE3762745D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylthiazol.
DE3586638D1 (de) Verfahren zur herstellung von vanadylphthalocyanin.
DE3578062D1 (de) Verfahren zur herstellung von iodbenzol.
DE3763558D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylpyridin.
DE3577854D1 (de) Verfahren zur herstellung von aethylenkopolymer.
DE3773889D1 (de) Verfahren zur herstellung von merkaptomethylphenolen.
DE3381934D1 (de) Verfahren zur herstellung von shampoos.
DE3381203D1 (de) Verfahren zur herstellung von uridindiphosphat-n-acetylgalactosamin.
AT399885B (de) Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren
DE3576817D1 (de) Verfahren zur herstellung von aminen.
DE3585219D1 (de) Verfahren zur herstellung von n-formyl-alpha-aspartyl-phenylalaninen.
DE3382369D1 (de) Verfahren zur herstellung von blockcopolyamiden.
DE3579858D1 (de) Verfahren zur herstellung von p-isobutylstyrol.
DE3575133D1 (de) Verfahren zur herstellung von 1-alkyl- oder 1-cycloalkylpiperazinen.
DE3584754D1 (de) Verfahren zur herstellung von arylalkylketonen.
DE3776164D1 (de) Verfahren zur herstellung von komplexen perovskittypverbindungen.
DE3769076D1 (de) Verfahren zur herstellung von fluorbenzaldehyden.
DE3766910D1 (de) Verfahren zur herstellung von dihydrocyclocitral.
DE3581667D1 (de) Verfahren zur herstellung von 5-deoxy-l-arabinose.
ATA304487A (de) Verfahren zur herstellung von 9alpha-hydroxy-4-androsten-3,17-dion

Legal Events

Date Code Title Description
ELA Expired due to lapse of time